Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harrow Inc (NQ: HROW )

42.90 -0.98 (-2.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harrow Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Earnings Scheduled For March 19, 2024
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Earnings Preview: Harrow Health
Via Benzinga
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
From Harrow, Inc.
Via Business Wire
Recap: Harrow Q3 Earnings
Via Benzinga
Harrow Health's Earnings Outlook
Via Benzinga
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
From Harrow, Inc.
Via Business Wire
Harrow Announces New Appointments to its Board of Directors
From Harrow, Inc.
Via Business Wire
Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
From Harrow, Inc.
Via Business Wire
Melt Pharmaceuticals Provides Corporate Update
From Melt Pharmaceuticals, Inc.
Via Business Wire
Harrow Partners with Leading Healthcare Market Access Technology Platforms
From Harrow, Inc.
Via Business Wire
7 Short-Squeeze Stocks That Are Screaming for Speculation
If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you. 
Via InvestorPlace
Harrow Completes Transfer of the TRIESENCE® New Drug Application
From Harrow, Inc.
Via Business Wire
Harrow to Present at Two Investor Conferences in November
From Harrow, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Is Eyecare-Focused Harrow Health Stock Trading Lower Today?
Harrow Health Inc (NASDAQ: HROW) reported Q3 revenues of $34.3 million, an increase of 50% Y/Y, missing the consensus of $37 
Via Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
Beauty Health Reports Downbeat Results, Joins Harrow, Fisker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Tuesday, with the Nasdaq futures gaining around 45 points this morning. 
Via Benzinga
Home Depot, Beauty Health And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Harrow Announces Third Quarter 2023 Financial Results
From Harrow, Inc.
Via Business Wire
Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023
From Harrow, Inc.
Via Business Wire
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
From Harrow, Inc.
Via Business Wire
Harrow Health, Inc. Changes Corporate Name to Harrow, Inc.
From Harrow Health, Inc.
Via Business Wire
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
From Melt Pharmaceuticals, Inc.
Via Business Wire
Harrow Announces Second Quarter 2023 Financial Results
From Harrow Health, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.